90.40
+0.81(+0.90%)
Currency In CNY
Address
288 Fute Zhong Road
Shanghai, 200131
China
Phone
86 21 5046 1111
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
39414
First IPO Date
May 08, 2018
| Name | Title | Pay | Year Born |
| Dr. Qing Yang Ph.D. | Co-Chief Executive Officer & Executive Director | 9.38M | 1969 |
| Dr. Minzhang Chen Ph.D. | Co-Chief Executive Officer & Executive Director | 16.72M | 1969 |
| Dr. Ge Li Ph.D. | Co-Founder, Executive Chairman, President & Chief Executive Officer | 41.87M | 1967 |
| Mr. Zhaohui Zhang | Chief Operating Officer of China, Executive Vice President & Executive Director | 8.07M | 1969 |
| Mr. Ruijia Tang | IR Director | 0 | N/A |
| Dr. Jingchao Dong Ph.D. | Senior Vice President & RCS Senior Advisor | 0 | N/A |
| Ms. Ming Shi | Senior Vice President & Chief Financial Officer | 0 | 1974 |
| Mr. Tao Guo Ph.D. | Senior Vice President and Head of RCS BD&IPM | 0 | N/A |
| Dr. Youchu Wang Ph.D. | Senior Vice President & Head of STA API Early Phase Development | 0 | N/A |
| Dr. Howard Wu J.D. | Senior Vice President, General Counsel, Global Head of HR & Deputy Director of WuXi AppTec Management Institute | 0 | N/A |
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.